Gwan Sun Lee
67Patents
11h-index
125Co-inventors
81Inventor score
Filing activity: May 18, 1998 → Mar 12, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7736653B2 | Pharmaceutical composition comprising an immunoglobulin Fc region as a carrier | Chemistry; Metallurgy | 68 | Expired |
| US8124094B2 | Immunoglobulin Fc fragment modified by non-peptide polymer and pharmaceutical composition comprising the same | Chemistry; Metallurgy | 60 | Active |
| US7737260B2 | Protein complex using an immunoglobulin fragment and method for the preparation thereof | Chemistry; Metallurgy | 48 | Expired |
| US6515116B2 | Method of preparing form II crystals of clarithromycin | Emerging Cross-Sectional Technologies | 35 | Expired |
| US8263084B2 | Pharmaceutical composition for treating obesity-related disease comprising insulinotropic peptide conjugate | Chemistry; Metallurgy | 31 | Active |
| US6605697B1 | Modified E. coli enterotoxin II signal peptide and a microorganism expressing a fusion protein of a said peptide and a heterologous protein | Emerging Cross-Sectional Technologies | 27 | Expired |
| US8110665B2 | Pharmaceutical composition comprising an immunoglobulin FC region as a carrier | Chemistry; Metallurgy | 25 | Active |
| US8029789B2 | Method for the mass production of immunoglobulin constant region | Chemistry; Metallurgy | 23 | Expired |
| US6506886B1 | Method of preparing form II crystals of clarithromycin | Chemistry; Metallurgy | 19 | Expired |
| US6809188B1 | Method of preparing clarithromycin | Human Necessities | 18 | Expired |
| US6444796B1 | Method of preparing form II crystals of clarithromycin | Human Necessities | 17 | Expired |
| US8476230B2 | Insulinotropic complex using an immunoglobulin fragment | Human Necessities | 11 | Active |
| US7470707B2 | Crystalline monohydrate clopidogrel naphthalenedisulfonate and process of preparation | Human Necessities | 10 | Expired |
| US8163889B2 | Physiologically active polypeptide conjugate having prolonged in vivo half-life | Human Necessities | 8 | Active |
| US9422349B2 | N-terminal modified exendin-4 | Chemistry; Metallurgy | 6 | Active |
| US8188102B2 | Amide derivative for inhibiting the growth of cancer cells | Chemistry; Metallurgy | 6 | Active |
| US7202360B2 | Method for preparing risperidone | Chemistry; Metallurgy | 6 | Expired |
| US9636420B2 | Polypeptide complex comprising non-peptidyl polymer having three functional ends | Chemistry; Metallurgy | 6 | Active |
| US7718399B2 | Expression vector for secreting antibody fragment using E. coli signal sequence and method for mass-producing antibody fragment | Chemistry; Metallurgy | 5 | Active |
| US8003658B2 | Quinazoline derivatives for inhibiting cancer cell growth and method for the preparation thereof | Chemistry; Metallurgy | 5 | Active |
| US8097706B2 | Methods for preparing capecitabine and beta-anomer-rich trialkyl carbonate compound used therein | Emerging Cross-Sectional Technologies | 5 | Active |
| US6093814A | Process for preparation of cefdinir | Human Necessities | 5 | Expired |
| US6388091B1 | Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-{(2-methyl-1H-imidazol-1-yl)methyl}-4H-carbazol-4-one | Chemistry; Metallurgy | 4 | Expired |
| US7157576B2 | Crystalline acid salts of cefdinir and process for preparing cefdinir using same | Chemistry; Metallurgy | 3 | Expired |
| US6130336A | Process for preparing paclitaxel | Emerging Cross-Sectional Technologies | 3 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.